Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Aspen purchases international OTC medicines from GSK for £164mm

Executive Summary

For £164mm ($263mm), GlaxoSmithKline PLC has sold to Aspen Pharmacare Holdings Ltd.--a South African pharmaco in which GSK holds a minority stake--a set of 19 deprioritized OTC products available in international markets.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase
    • Reverse Licensing

Related Companies

UsernamePublicRestriction

Register